
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Looking Farther Afield |
| Synonymous Single Nucleotide Polymorphisms: Now Look Who's Talking |
|---|
|
|
|---|
3.4 times higher for the SNP-containing haplotype than for the wild-type protein. Again, these data argue for consideration of silent mutations in the context of disease association and pharmacogenetic studies. Thus, what does this mean for molecular epidemiology studies? As we move back and forth between candidate gene approaches and whole genome scans, these two studies give one pause: We definitely must not ignore synonymous changes within haplotypes. The findings here also make sense in the context of understanding discrepancies between studies that focus on a single nonsynonymous SNP; it is just not that simple. | Expressions of Interest |
|---|
|
|
|---|
8,500 genes. When comparing the CEU population with either the CHB or JPT population, 939 and 756 genes differed significantly in expression, respectively. When comparing the CHB with the JPT group, only 27 genes differed significantly in expression. Upon combining the CHB and JPT samples and comparing with the CEU group, 1,097 genes significantly differed in expression. However, most expression differences were not of a great magnitude. Only 35 genes had more than a 2-fold mean expression between the CEU group and the combined CHB/JPT group. Of these genes, UGT2B17 had the largest difference, with a mean expression 22 times higher than the combined CHB/JPT group. The authors replicated their results using 24 samples from the Han Chinese of Los Angeles; only one gene differed in expression between the Han Chinese of Los Angeles and the CHB/JPT group, but 21 differed significantly from the CEU group. Cluster analyses of all four populations revealed two distinct groups: one consisted of 59 of 60 CEU individuals, whereas the other consisted of all three Asian groups and one CEU individual. To determine whether these differences were driven by genotype, the authors carried out genome-wide analysis for each of the 1,097 phenotypes. For the vast majority of genes, significant expression differences were due to differences in genotype frequency between the populations. For instance, 69% of the CEU group possessed the more highly expressed allele of the UGT2B17 gene, whereas only 15% of the CHB/JPT group did. This study is reassuring in that the protein product of many genes deemed to have functional significance (e.g., nonsynonymous SNPs) seem to track as expected. Couzin (5), in an editorial in Science, remarked specifically about the importance of studying those genes that seem to stand out between groups. Could these genes help explain differences in disease risk? Importantly, the genes that were differentially expressed between the groups are not the usual suspects interrogated to better understand differences in cancer risk between populations. For example, UGT2B17 is a steroid metabolism gene that may also be involved in drug metabolism (5). The authors plan to study other racial and ethnic groups to determine what patterns arise. Received 3/28/07; accepted 3/28/07.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |